Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase

Angiopoietin-like protein 4 (ANGPTL4) regulates lipid partitioning by inhibiting circulating and tissue lipoprotein lipase (LPL); ANGPTL4 loss-of-function variants improve insulin sensitivity and reduce type 2 diabetes (T2D) risk with mechanisms partially unknown. This study was designed to explore metabolic implications of differential ANGPTL4 and LPL expression in human adipose tissue (AT). We recruited eighty-eight obese individuals, with and without abnormal glucose metabolism (AGM), undergoing bariatric surgery; visceral AT (VAT) fragments were obtained intra-operatively and analyzed by immunohistochemistry and mRNA by rt-PCR. Data on hepatic ANGPTL4 mRNA were available for 40 participants. VAT ANGPTL4 expression was higher in AGM individuals than in those with normal glucose tolerance (NGT) and associated with VAT inflammation, insulin resistance, and presence of adipocyte size heterogeneity. Increased ANGPTL4 was associated with AGM with OR = 5.1 (95% C.I.: 1.2–23; p = 0.02) and AUROC = 0.76 (95% C.I.: 1.2–23; p < 0.001). High LPL was associated with the detection of homogeneous adipocyte size, reduced microvessel density, and higher HIF-1α levels and inversely correlated to blood transaminases. In conclusion, in obese individuals, VAT ANGPTL4 levels are increased in the presence of local inflammation and AGM. Conversely, higher LPL expression describes a condition of increased lipid storage in adipocytes, which may serve as a protective mechanism against ectopic fat accumulation and related metabolic disease in obesity.

[1]  G. Silecchia,et al.  Relationship between hepatic and systemic angiopoietin‐like 3, hepatic Vitamin D receptor expression and NAFLD in obesity , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[2]  G. Silecchia,et al.  Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease , 2020, Diabetes/metabolism research and reviews.

[3]  G. Silecchia,et al.  Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP , 2020, Surgical Endoscopy.

[4]  K. Kos,et al.  Circulating and tissue specific transcription of angiopoietin-like protein 4 in human Type 2 diabetes. , 2020, Metabolism: clinical and experimental.

[5]  P. Bai,et al.  The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism , 2020, Genes & development.

[6]  C. Sirtori,et al.  Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: new therapeutic approaches for the treatment of atherogenic dyslipidemia. , 2020, Pharmacological research.

[7]  F. Beguinot,et al.  Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes , 2020, Frontiers in Physiology.

[8]  American Diabetes Association.  1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2020 , 2019, Diabetes Care.

[9]  J. Kong,et al.  VDR regulates energy metabolism by modulating remodeling in adipose tissue. , 2019, European journal of pharmacology.

[10]  F. Hu,et al.  Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. , 2019, The lancet. Diabetes & endocrinology.

[11]  H. Hermanns,et al.  Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[12]  S. Kersten.  New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk , 2019, Current opinion in lipidology.

[13]  A. Lenzi,et al.  ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity , 2018, Obesity science & practice.

[14]  S. Kersten,et al.  Angiopoietin-like 4 promotes the intracellular cleavage of lipoprotein lipase by PCSK3/furin in adipocytes , 2018, The Journal of Biological Chemistry.

[15]  Alexander E. Lopez,et al.  Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes , 2018, Nature Communications.

[16]  S. Kersten,et al.  Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue. , 2018, Journal of clinical lipidology.

[17]  G. Silecchia,et al.  Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity , 2018, Nutrients.

[18]  T. Horvath,et al.  Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis , 2018, JCI insight.

[19]  S. Kersten,et al.  Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota , 2018, Diabetologia.

[20]  Matthew J. Potthoff,et al.  Angiopoietin-like 4 directs uptake of dietary fat away from adipose during fasting , 2017, Molecular metabolism.

[21]  W. Geldenhuys,et al.  Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases. , 2017, Drug discovery today.

[22]  Li Wei,et al.  Angiopoietin-like protein 4 improves glucose tolerance and insulin resistance but induces liver steatosis in high-fat-diet mice. , 2016, Molecular medicine reports.

[23]  E. Garí,et al.  Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis. , 2016, Journal of hepatology.

[24]  C. Catalano,et al.  Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes. , 2016, Clinical science.

[25]  S. Kersten,et al.  Regulation of lipid metabolism by angiopoietin-like proteins , 2016, Current opinion in lipidology.

[26]  S. Kersten,et al.  Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes , 2014, BMJ Open Diabetes Research and Care.

[27]  P. Trayhurn.  Hypoxia and adipocyte physiology: implications for adipose tissue dysfunction in obesity. , 2014, Annual review of nutrition.

[28]  N. Tan,et al.  Fatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise , 2014, Proceedings of the National Academy of Sciences.

[29]  M. Maranghi,et al.  The angiopoietin-like protein 3: a hepatokine with expanding role in metabolism , 2013, Current opinion in lipidology.

[30]  S. Kersten,et al.  Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue , 2012, BMC Physiology.

[31]  M. Lombardi,et al.  Impact of increased visceral and cardiac fat on cardiometabolic risk and disease , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[32]  D. Deb,et al.  Targeted Expression of Human Vitamin D Receptor in Adipocytes Decreases Energy Expenditure and Induces Obesity in Mice* , 2011, The Journal of Biological Chemistry.

[33]  P. Trayhurn,et al.  Fatty Acids and Hypoxia Stimulate the Expression and Secretion of the Adipokine ANGPTL4 (Angiopoietin-Like Protein 4/ Fasting-Induced Adipose Factor) by Human Adipocytes , 2011, Lifestyle Genomics.

[34]  K. Feingold,et al.  The acute phase response stimulates the expression of angiopoietin like protein 4. , 2010, Biochemical and biophysical research communications.

[35]  Y. Hu,et al.  GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4 , 2009, Journal of Lipid Research.

[36]  Eric Boerwinkle,et al.  Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. , 2008, The Journal of clinical investigation.

[37]  S. Schinner,et al.  Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications , 2009 .

[38]  K. Strissel,et al.  Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications , 2007, Diabetes.

[39]  R. Orlando,et al.  Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy , 2007, Nutrition & metabolism.

[40]  M. Matsuda,et al.  Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation , 2007, Diabetes.

[41]  Eric Boerwinkle,et al.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL , 2007, Nature Genetics.

[42]  John A Spertus,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary , 2005, Critical pathways in cardiology.

[43]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[44]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[45]  Kok Weng Chan,et al.  Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Krauss,et al.  Diagnosis and management of the metabolic syndrome , 2005 .

[47]  W. Wahli,et al.  The Direct Peroxisome Proliferator-activated Receptor Target Fasting-induced Adipose Factor (FIAF/PGAR/ANGPTL4) Is Present in Blood Plasma as a Truncated Protein That Is Increased by Fenofibrate Treatment* , 2004, Journal of Biological Chemistry.

[48]  Huijun Sun,et al.  Overexpression of Lipoprotein Lipase in Transgenic Watanabe Heritable Hyperlipidemic Rabbits Improves Hyperlipidemia and Obesity* , 2004, Journal of Biological Chemistry.

[49]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[50]  P. Kern,et al.  The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans. , 1990, The New England journal of medicine.

[51]  M. Greenwood.  The relationship of enzyme activity to feeding behavior in rats: lipoprotein lipase as the metabolic gatekeeper. , 1985, International journal of obesity.